The Pharmaceuticals in Dosage market size in France experienced a downward trend from 2013 to 2023, with the market value decreasing from $94.731 billion to $70.241 billion. This represents an overall decline with significant year-on-year variations, including substantial drops in 2015 (-17.3%) and 2022 (-11.01%). Despite intermittent growth periods, such as 2018 (3.5%) and 2021 (2.55%), the market did not sustain long-term positive momentum. The last two years witnessed a decline of 2.11% in 2023 and an average annual drop of 1.64% over the past five years.

Future trends to watch for include:

Continued shrinkage in market size, as evidenced by the forecasted 5-year CAGR of -1.75% leading to an 8.45% reduction by 2028.
Potential market adjustments driven by innovations in pharmaceutical technologies and changes in healthcare policies.
The impact of emerging markets and global economic trends on France’s pharmaceutical sector.
Influence of regulatory changes and intellectual property laws.